Cabot Corporation

About: Cabot Corporation is a company organization based out in Boston, Massachusetts, United States. It is known for research contribution in the topics: Carbon black & Carbon. The organization has 1279 authors who have published 1399 publications receiving 36736 citations.

Methods of hard facing

Abstract: A method of forming a hard surfacing on a metal article is provided based upon forming a weld wire with a diffusion layer containing boron and depositing the wire on the surface to be hard surfaced by means of an electric arc to form a substantially uniform boron containing alloy weldment composition.

Fine particle size activated carbon

Abstract: Disclosed herein are activated carbon having a particle size distribution of d 95 ranging from 1 μm to 28 μm and a d 95 /d 50 ratio ranging from 1.5 to 3, compositions comprising such activated carbons and methods of making the same, and methods of mercury removal from flue gas generated from coal combustion by injecting activated carbon into the flue gas.

Drug testing: Technical complications of a complex social issue

Abstract: To control the adverse effects of substance abuse, urinary drug testing has become common practice in some occupational settings. Although it is virtually impossible to assess accurately the impact of drug abuse at work, increased accidents and absenteeism as well as impaired productivity have been attributed to drug abuse. The major analytical techniques used to screen for illegal drug use are thin-layer chromatography and enzyme- and radioimmunoassays. Gas chromatography-mass spectrometry is uniformly recommended to confirm any positive screening test. The major technical problem in interpreting screening tests is that the presence of a substance in the urine indicates merely exposure to the drug, not necessarily intoxication, habituation, or addiction. Since no certifying criteria are available to insure quality control among laboratories performing urinary drug testing, results may vary widely. In fact, a study conducted by the Centers for Disease Control suggests that poor performance of some laboratories may adversely affect the treatment of drug abuse. The Federal Rehabilitation Act (1973, section 504) prohibits discrimination against the handicapped, which includes both drug abuse and alcoholism. Legal challenges to urinary drug testing have focused on issues related to the right to privacy and freedom from unreasonable searches. Because of the wide-ranging legal, ethical, and medical ramifications of drug-screening programs, careful review of these issues is recommended before an organization establishes such a program.